ZAINEB SHAMS: Open Payments
NPI 1487905709 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,939 in 179 payments from 34 companies in 2025. Trend: 2023 $15,348 · 2024 $17,498 · 2025 $21,939
Speaker / faculty: $16,500Food & beverage: $4,269Travel & lodging: $689Consulting: $480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 35 | $16,995 |
| Daiichi Sankyo Inc. | 24 | $1,539 |
| PFIZER INC. | 12 | $796 |
| Janssen Biotech, Inc. | 20 | $451 |
| Gilead Sciences, Inc. | 8 | $274 |
| Novartis Pharmaceuticals Corporation | 12 | $190 |
| E.R. Squibb & Sons, L.L.C. | 11 | $155 |
| EMD Serono, Inc. | 2 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $143 |
| Merck Sharp & Dohme LLC | 6 | $128 |
Products named: DATROWAY, IMFINZI, XTANDI, Enhertu, TAGRISSO, RYBREVANT, Trodelvy, OPDIVO.
Industry payments across TX — which companies pay providers there.
